{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:54:28Z","timestamp":1771476868877,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03568-4","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T18:01:49Z","timestamp":1700071309000},"page":"763-774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Contrast CT radiomic features add value to prediction of prognosis in adrenal cortical carcinoma"],"prefix":"10.1007","volume":"83","author":[{"given":"Jiacheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"3568_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/er.2013-1029","volume":"35","author":"T Else","year":"2014","unstructured":"T. Else, A.C. Kim, A. Sabolch et al. Adrenocortical carcinoma. Endocr. Rev. 35, 282\u2013326 (2014). https:\/\/doi.org\/10.1210\/er.2013-1029","journal-title":"Endocr. Rev."},{"key":"3568_CR2","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1245\/s10434-014-3931-z","volume":"21","author":"J Pura","year":"2014","unstructured":"J. Pura, M. Dinan, S. Reed et al. Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States. Ann. Surg. Oncol. 21, 3509\u20133514 (2014). https:\/\/doi.org\/10.1245\/s10434-014-3931-z","journal-title":"Ann. Surg. Oncol."},{"key":"3568_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1530\/EJE-13-0142","volume":"169","author":"TM Kerkhofs","year":"2013","unstructured":"T.M. Kerkhofs, R.H. Verhoeven, H.J. Bonjer et al. Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data. Eur. J. Endocrinol. 169, 83\u201389 (2013). https:\/\/doi.org\/10.1530\/EJE-13-0142","journal-title":"Eur. J. Endocrinol."},{"key":"3568_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1530\/EJE-13-0242","volume":"169","author":"M Terzolo","year":"2013","unstructured":"M. Terzolo, A.E. Baudin, A. Ardito et al. Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. Eur. J. Endocrinol. 169, 263\u2013270 (2013). https:\/\/doi.org\/10.1530\/EJE-13-0242","journal-title":"Eur. J. Endocrinol."},{"key":"3568_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/cncr.24030","volume":"115","author":"M Fassnacht","year":"2009","unstructured":"M. Fassnacht, S. Johanssen, M. Quinkler et al. Limited prognostic value of the 2004 international union against cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification. Cancer 115, 243\u2013250 (2009). https:\/\/doi.org\/10.1002\/cncr.24030","journal-title":"Cancer"},{"key":"3568_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1210\/jc.2013-2856","volume":"99","author":"T Else","year":"2014","unstructured":"T. Else, A.R. Williams, A. Sabolch et al. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 99, 455\u2013461 (2014). https:\/\/doi.org\/10.1210\/jc.2013-2856","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3568_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1530\/EJE-21-0510","volume":"186","author":"YS Elhassan","year":"2022","unstructured":"Y.S. Elhassan, B. Altieri, S. Berhane et al. S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study. Eur. J. Endocrinol. 186, 25\u201336 (2022). https:\/\/doi.org\/10.1530\/EJE-21-0510","journal-title":"Eur. J. Endocrinol."},{"key":"3568_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1210\/jc.2014-3182","volume":"100","author":"F Beuschlein","year":"2015","unstructured":"F. Beuschlein, J. Weigel, W. Saeger et al. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J. Clin. Endocrinol. Metab. 100, 841\u2013849 (2015). https:\/\/doi.org\/10.1210\/jc.2014-3182","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3568_CR9","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.eururo.2013.11.006","volume":"65","author":"A Berruti","year":"2014","unstructured":"A. Berruti, M. Fassnacht, H. Haak et al. Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. Eur. Urol. 65, 832\u2013838 (2014). https:\/\/doi.org\/10.1016\/j.eururo.2013.11.006","journal-title":"Eur. Urol."},{"key":"3568_CR10","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","volume":"179","author":"M Fassnacht","year":"2018","unstructured":"M. Fassnacht, O.M. Dekkers, T. Else et al. European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors. Eur. J. Endocrinol. 179, G1\u2013G46 (2018). https:\/\/doi.org\/10.1530\/EJE-18-0608","journal-title":"Eur. J. Endocrinol."},{"key":"3568_CR11","doi-asserted-by":"publisher","first-page":"e220114","DOI":"10.1530\/EC-22-0114","volume":"11","author":"W Lin","year":"2022","unstructured":"W. Lin, J. Dai, J. Xie et al. S-GRAS score performs better than a model from SEER for patients with adrenocortical carcinoma. Endocr. Connect 11, e220114 (2022). https:\/\/doi.org\/10.1530\/EC-22-0114","journal-title":"Endocr. Connect"},{"key":"3568_CR12","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1148\/radiol.2016152234","volume":"281","author":"Y Huang","year":"2016","unstructured":"Y. Huang, Z. Liu, L. He et al. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) Non\u2014Small Cell Lung Cancer. Radiology 281, 947\u2013957 (2016). https:\/\/doi.org\/10.1148\/radiol.2016152234","journal-title":"Radiology"},{"key":"3568_CR13","doi-asserted-by":"publisher","first-page":"e2028608","DOI":"10.1001\/jamanetworkopen.2020.28086","volume":"3","author":"Y Yu","year":"2020","unstructured":"Y. Yu, Y. Tan, C. Xie et al. Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer. JAMA Netw. Open 3, e2028608 (2020). https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.28086","journal-title":"JAMA Netw. Open"},{"key":"3568_CR14","doi-asserted-by":"publisher","first-page":"100694","DOI":"10.1016\/j.xcrm.2022.100694","volume":"3","author":"L Jiang","year":"2022","unstructured":"L. Jiang, C. You, Y. Xiao et al. Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer. Cell Rep. Med. 3, 100694 (2022). https:\/\/doi.org\/10.1016\/j.xcrm.2022.100694","journal-title":"Cell Rep. Med."},{"key":"3568_CR15","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","volume":"26","author":"R Lib\u00e9","year":"2015","unstructured":"R. Lib\u00e9, I. Borget, C.L. Ronchi et al. Prognostic factors in stage III\u2013IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. Ann. Oncol. 26, 2119\u20132125 (2015). https:\/\/doi.org\/10.1093\/annonc\/mdv329","journal-title":"Ann. Oncol."},{"key":"3568_CR16","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1002\/cncr.23886","volume":"113","author":"KY ilimoria","year":"2008","unstructured":"K.Y. ilimoria, W.T. Shen, D. Elaraj et al. Adrenocortical carcinoma in the United States. Cancer 113, 3130\u20133136 (2008). https:\/\/doi.org\/10.1002\/cncr.23886","journal-title":"Cancer"},{"key":"3568_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/jamasurg.2015.4516","volume":"151","author":"Y Kim","year":"2016","unstructured":"Y. Kim, G.A. Margonis, J.D. Prescott et al. Nomograms to predict recurrence-free and overall survival after curative resection of adrenocortical carcinoma. JAMA Surg. 151, 365\u2013373 (2016). https:\/\/doi.org\/10.1001\/jamasurg.2015.4516","journal-title":"JAMA Surg."},{"key":"3568_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/RLU.0000000000004593","volume":"48","author":"R Lib\u00e9","year":"2023","unstructured":"R. Lib\u00e9, A. Pais, F. Violon et al. Positive correlation between 18F-FDG uptake and tumor-proliferating antigen Ki-67 expression in adrenocortical carcinomas. Clin. Nucl. Med 48, 381\u2013386 (2023). https:\/\/doi.org\/10.1097\/RLU.0000000000004593","journal-title":"Clin. Nucl. Med"},{"key":"3568_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1148\/radiol.2019190913","volume":"294","author":"JE Park","year":"2020","unstructured":"J.E. Park, H.S. Kim, S.Y. Park et al. Prediction of core signaling pathway by using diffusion- and perfusion-based MRI radiomics and next-generation sequencing in isocitrate dehydrogenase wild-type glioblastoma. Radiology 294, 388\u2013397 (2020). https:\/\/doi.org\/10.1148\/radiol.2019190913","journal-title":"Radiology"},{"key":"3568_CR20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1148\/radiol.2020191470","volume":"294","author":"GW Ji","year":"2020","unstructured":"G.W. Ji, F.P. Zhu, Q. Xu et al. Radiomic features at contrast-enhanced CT predict recurrence in early-stage hepatocellular carcinoma: a multi-institutional study. Radiology 294, 568\u2013579 (2020). https:\/\/doi.org\/10.1148\/radiol.2020191470","journal-title":"Radiology"},{"key":"3568_CR21","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/bjs\/znab191","volume":"108","author":"H Tibermacine","year":"2021","unstructured":"H. Tibermacine, P. Rouanet, M. Sbarra et al. Radiomics modelling in rectal cancer to predict disease-free survival: evaluation of different approaches. Br. J. Surg. 108, 1243\u20131250 (2021). https:\/\/doi.org\/10.1093\/bjs\/znab191","journal-title":"Br. J. Surg."},{"key":"3568_CR22","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1007\/s00259-022-05773-1","volume":"49","author":"G Yang","year":"2022","unstructured":"G. Yang, P. Nie, L. Yan et al. The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study. EJNMMI 49, 2949\u20132959 (2022). https:\/\/doi.org\/10.1007\/s00259-022-05773-1","journal-title":"EJNMMI"},{"key":"3568_CR23","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1007\/s00259-023-06187-3","volume":"50","author":"S Ghezzo","year":"2023","unstructured":"S. Ghezzo, P. Mapelli, C. Bezzi et al. Role of [68Ga] Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer. EJNMMI 50, 2548\u20132560 (2023). https:\/\/doi.org\/10.1007\/s00259-023-06187-3","journal-title":"EJNMMI"},{"key":"3568_CR24","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/clinem\/dgac470","volume":"107","author":"J Lippert","year":"2022","unstructured":"J. Lippert, B. Altieri, B. Morrison et al. Prognostic role of targeted methylation analysis in paraffin-embedded samples of adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 107, 2892\u20132899 (2022). https:\/\/doi.org\/10.1210\/clinem\/dgac470","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03568-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03568-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03568-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T02:16:42Z","timestamp":1709173002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03568-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["3568"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03568-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"26 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional Review Board approval was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients and\/or legal guardians in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}